Photobiomodulation Science

Home / Visual articles / Light in medicine

Visual article / PBM Science

Light in medicine

Treatments, diagnostics and research on light and health.

AI-generated article and illustrations, partially curated by the site administrator.

Published

Treatments

Photobiomodulation

Usually red and near-infrared light

Watercolor-style illustration of a red LED panel illuminating layered skin, with enlarged cells in the foreground.
Light absorption can influence several cellular and tissue processes.

Light absorbed by endogenous targets can modify cellular and tissue function without intended tissue destruction. Responses can involve metabolism, inflammatory processes, signaling and tissue repair; the mechanisms depend on the biological context and exposure.

PBM uses lasers or LEDs and is investigated across pain, wound-healing, neurological and other applications. A defined clinical use is the prevention of oral mucositis with specified intraoral protocols in selected adult oncology settings. Evidence and treatment parameters vary by indication.1,2,3,4

Photodynamic therapy

A photosensitizer, matched light and oxygen

Watercolor-style illustration of photosensitizer from a dropper and red light acting on a localized skin target.
Photosensitizer + light + oxygen → local oxidative injury.

A light-sensitive drug—or a precursor that produces a photosensitizer within tissue—is activated by an appropriate wavelength. In conventional PDT, the excited sensitizer transfers energy or electrons to generate reactive species that damage cells and other local targets.

Clinical uses include actinic keratoses, selected superficial skin cancers and some other accessible lesions. Antimicrobial PDT applies the same broad principle to microbes. The drug or precursor, illumination and target together determine the treatment; light alone is only one component.1,5

Bright light therapy

Visible light reaching the eyes

Watercolor-style illustration of a man with short dark hair and a beard holding a mug near a bright light box in daylight.
Retinal light input influences brain pathways for timing and mood.

Retinal photoreceptors send signals to brain pathways involved in circadian timing, alertness and mood. This treatment acts through the eyes; the timing of exposure is part of the intervention.

Used for seasonal depression and selected circadian sleep–wake disorders. Clinical trials also support bright light as an adjunct in nonseasonal depression, although protocols and accompanying treatments vary.1,2,6

UV phototherapy

Controlled UVB or UVA exposure

Illustration of a clinical UV lamp illuminating a forearm, with a magnified skin and immune-cell cutaway.
Controlled UV exposure changes skin and immune responses.

Ultraviolet light changes immune activity and cell proliferation in skin. Narrowband UVB is used for conditions such as psoriasis and vitiligo; PUVA combines a psoralen photosensitizer with UVA.

The spectrum, exposure and treatment schedule are selected for the condition. Clinical protocols also account for acute skin reactions and cumulative UV exposure.1,7

Antimicrobial blue light

Violet and blue light

Illustration of blue light illuminating rod-shaped bacteria and endogenous pigment particles on a surface.
Endogenous microbial pigments absorb light and can drive oxidative damage.

Light can excite molecules naturally present in microbes, including porphyrins and flavins. The resulting reactive species can damage microbial structures without an added photosensitizer.

Research includes localized infections, biofilms and acne-associated microbes. Susceptibility differs between organisms, and many proposed applications remain investigational; laboratory killing does not by itself establish a clinical treatment.1,8

Neonatal jaundice phototherapy

Blue light absorbed by bilirubin

Watercolor-style illustration of a caregiver beside a newborn with protective eye covering under a blue phototherapy lamp.
Bilirubin photoproducts can be eliminated more readily.

Illumination changes bilirubin into isomers and other photoproducts that the infant can excrete more readily. The main target is the bilirubin molecule rather than a general stimulation of tissue.

This is a standard neonatal treatment when clinical thresholds are met. Decisions depend on bilirubin concentration, the infant’s age and relevant risk factors.1,9

Selective skin treatments

Lasers and intense pulsed light (IPL)

Illustration of a dermatology laser directing energy toward a hair follicle in a layered skin cutaway.
Preferential absorption concentrates energy in a selected skin target.

Wavelength and pulse duration help concentrate energy in selected absorbing structures. Hemoglobin and melanin are common targets, allowing localized heating of blood vessels or hair follicles.

Examples include vascular-lesion treatment and hair reduction. Short-pulse lasers can also fragment tattoo pigment. Different targets require different optical and pulse characteristics; IPL and lasers are distinct light sources.1,10

Laser resurfacing

Ablative or nonablative laser treatment

Illustration of fractional laser microcolumns in skin, with untreated tissue between the columns.
Fractional systems treat spaced zones rather than the entire surface.

Resurfacing removes superficial tissue or creates controlled thermal injury to promote remodeling. Ablative systems remove tissue; nonablative systems heat selected tissue while preserving more of the surface.

Fractional treatment creates spaced microscopic treatment zones with intervening tissue left untreated. Applications include scars and photoaged skin, with recovery and effects varying by procedure.1,11

Laser surgery

Focused energy at a surgical target

Illustration of a surgical optical fiber applying light to a small internal tissue region, with an eye-procedure inset.
Focused exposure enables localized removal, reshaping or coagulation.

Laser energy can cut, coagulate, vaporize or disrupt tissue. The interaction depends on wavelength, pulse characteristics, focusing and the target; delivery through optical fibers makes some internal procedures possible.

Examples include corneal reshaping, retinal photocoagulation, endoscopic tissue removal and urinary-stone fragmentation. These procedures use different physical effects and equipment.1

Crosslinking & light curing

Light-driven strengthening and polymerization

Illustration of riboflavin and directed illumination at the cornea, alongside a tooth restoration under a dental curing light.
Light-activated chemistry can strengthen tissue or harden a material.

In corneal crosslinking, riboflavin and UVA initiate reactions that strengthen corneal tissue in selected keratoconus treatments. The clinical evidence depends on the procedure, including whether the epithelium is removed.

Light also activates photoinitiators in dental restorative materials, causing the resin to polymerize and harden. Both examples use light-driven chemistry to change material properties.1,12

Extracorporeal photopheresis

Psoralen and UVA, outside the body

Watercolor-style illustration of a seated patient connected by tubing to an external blood-processing and light-exposure chamber.
Collection → psoralen/UVA treatment → reinfusion.

A collected white-cell fraction is exposed to a psoralen photosensitizer and UVA, then reinfused. The treated cells can influence subsequent immune responses; only the collected fraction is illuminated.

Used in selected cutaneous T-cell lymphomas and graft-versus-host disease settings. This combines cell collection, photochemical treatment and reinfusion rather than exposing the whole body to light.13

Optogenetics

Genetically introduced light sensitivity

Illustration of an eye and magnified retinal cells, with gene delivery, introduced light-sensitive membrane proteins and an electrical response.
Gene delivery gives selected cells a new response to illumination.

Gene delivery introduces a light-sensitive protein into selected cells. Illumination can then control their electrical activity or other functions, offering cell-selective control that ordinary illumination does not provide.

Therapeutic research includes vision restoration in retinal disease. Human studies have reported early functional changes, but the cited studies are small and uncontrolled; these applications remain in clinical research.14,15

Diagnostics

Optical coherence tomography

OCT · tissue cross-sections

Illustration of an ophthalmic OCT scanner, an eye cutaway and a layered retinal cross-sectional image on a monitor.

Interference measurements of backscattered light reveal tissue microstructure. OCT is widely used to examine the retina and cornea; catheter-based systems can also image coronary arteries.1

Endoscopy

Illumination and imaging inside the body

Illustration of a flexible illuminated endoscope inside a stomach cutaway, with an internal surface image on a monitor.

A scope brings light and a camera to internal surfaces, such as the gastrointestinal tract or airways. Narrow-band illumination can enhance vascular contrast; capsule endoscopy images parts of the intestine.1

Light microscopy

Cells and tissue at high magnification

Illustration of a laboratory light microscope and a magnified stained-cell sample.

Optical magnification reveals cells and tissue architecture in blood smears, biopsies and other samples. Bright-field, confocal and multiphoton approaches use different forms of contrast and optical sectioning.1

Fluorescence imaging

Detecting emitted light

Illustration of fluorescence-guided tissue imaging, with a localized fluorescent region and a corresponding monitor view.

Excited molecules emit light that can highlight anatomy, perfusion or molecular targets. Uses include angiography and surgical guidance; selected fluorescent agents help identify cancerous tissue during defined procedures.1,16

Raman spectroscopy

A molecular fingerprint from scattered light

Illustration of an optical probe illuminating a tissue sample, with an illustrative spectrum on a monitor.

Small wavelength shifts reveal molecular vibrations and chemical composition. Raman methods can characterize tissue or samples without a fluorescent label; clinical adoption varies by application.1

Photoacoustic imaging

Light excitation, ultrasound detection

Watercolor-style illustration of light illuminating tissue beside an ultrasound probe, with a vascular image on a monitor.

Absorbed light pulses generate pressure waves detected as ultrasound. This maps optical absorbers, including hemoglobin; a combined optoacoustic–ultrasound system has a defined clinical use in breast-lesion assessment.1,17

Pulse oximetry

Estimating arterial oxygen saturation

Illustration of a fingertip pulse oximeter, showing the finger between the optical source and detector.

Red and infrared absorption in pulsatile blood helps estimate arterial oxygen saturation. The familiar finger or ear sensor is an optical measurement device used for bedside monitoring.1

Near-infrared spectroscopy

NIRS · tissue oxygenation and hemodynamics

Watercolor-style illustration of forehead optodes and a regional tissue-oxygenation monitor.

Near-infrared absorption measurements probe oxygenated and deoxygenated hemoglobin in tissue. Uses include regional oxygenation monitoring and functional brain research; diffuse optical tomography reconstructs spatial information from multiple measurements.1,18

Laser Doppler imaging

Blood flow from a frequency shift

Illustration of a laser measuring a forearm, with a magnified blood-vessel view and an illustrative Doppler signal.

Light scattered by moving red blood cells changes frequency. Detecting this Doppler shift provides information about microvascular perfusion, for example in assessments of skin and burn wounds.1

Laser speckle contrast imaging

Blood flow from changing speckle patterns

Illustration of a camera and laser above a hand, with a false-color perfusion display and a laser-speckle texture inset.

Coherent illumination produces a granular interference pattern. Blood-cell motion changes or blurs that pattern; image contrast is used to map relative perfusion across a surface.1

Flow cytometry

Measuring cells one by one

Illustration of individual cells in a flow stream crossing a laser, with collection optics, detectors and an illustrative scatter plot.

Cells pass through a light beam. Scattering and fluorescence reveal properties of individual cells and labeled markers, supporting blood-cancer and immune-cell analysis; some instruments can also sort cells.1

Optical laboratory assays

Color, fluorescence and other readouts

Illustration of a multiwell laboratory plate, pipette and optical plate reader.

A change in color or emitted light can report a molecule’s presence or concentration. Examples include ELISA, fluorescent genetic probes and optical readouts in some sequencing systems.1

Other light & health research

Sunlight & population health

Associations in populations

Watercolor-style illustration of people walking outdoors in daylight, with participant records on a clipboard.
Population data connect estimated exposure with health outcomes.

Epidemiological studies compare sunlight exposure with outcomes such as mortality, cardiovascular disease and cancer. Exposure may be estimated from time outdoors, ambient UV or other proxies.

These studies examine health correlations rather than a prescribed light treatment. Findings vary, and confounding by activity, lifestyle and other factors complicates causal interpretation.19

Circadian health

Light timing, daily rhythms and sleep

Watercolor-style illustration of daytime reading by a window and nighttime sleep, joined by a day–night timing motif.
Light across the day and night helps shape biological timing.

Research examines how the timing, intensity and spectrum of everyday light relate to circadian rhythms, sleep, alertness and health. Morning and evening light can have different effects on biological timing.

Topics include daylight exposure, light at night, shift work and lighting environments. This broader exposure research also informs the timed use of bright light therapy.1,2

Sources (19)
  1. Yun SH, Kwok SJJ (2017). Light in diagnosis, therapy and surgery ↗. Nature Biomedical Engineering.
  2. Oyama Y et al. (2026). Light therapy in medicine: where do we stand? ↗. Annals of Translational Medicine 14(3):35.
  3. Elad S et al. (2020). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy ↗. Cancer 126(19):4423–4431.
  4. American Society for Laser Medicine and Surgery (accessed 2026). Photobiomodulation ↗. Professional educational overview.
  5. Kandolf L et al. (2024). European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization ↗. Journal of the European Academy of Dermatology and Venereology 38:1024–1047.
  6. Menegaz de Almeida A et al. (2025). Bright Light Therapy for Nonseasonal Depressive Disorders: A Systematic Review and Meta-Analysis ↗. JAMA Psychiatry 82:38–46 (online 2024).
  7. Goulden V et al. (2022). British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022 ↗. British Journal of Dermatology 187:295–308.
  8. Huang S et al. (2023). The Parameters Affecting Antimicrobial Efficiency of Antimicrobial Blue Light Therapy: A Review and Prospect ↗. Biomedicines 11(4):1197.
  9. Kemper AR et al. (2022). Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation ↗. Pediatrics 150:e2022058859.
  10. Anderson RR, Parrish JA (1983). Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation ↗. Science 220:524–527.
  11. Manstein D et al. (2004). Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury ↗. Lasers in Surgery and Medicine 34:426–438.
  12. NICE (2013). Photochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia ↗. HealthTech guidance HTG319.
  13. Knobler R et al. (2020). European dermatology forum – updated guidelines on the use of extracorporeal photopheresis 2020 – part 1 ↗. Journal of the European Academy of Dermatology and Venereology 34:2693–2716.
  14. Sahel JA et al. (2021). Partial recovery of visual function in a blind patient after optogenetic therapy ↗. Nature Medicine 27:1223–1229.
  15. Lam BL et al. (2025). Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial ↗. eClinicalMedicine 87:103430.
  16. FDA (2024). FDA approves imaging drug to assist in detection of cancerous tissue following lumpectomy ↗. US Food and Drug Administration.
  17. FDA (2021). Imagio Breast Imaging System — P200003 ↗. US Food and Drug Administration.
  18. Jacques SL (2013). Optical properties of biological tissues: a review ↗. Physics in Medicine and Biology 58:R37–R61.
  19. Parkhouse T et al. (2025). The effects of sunlight exposure on mortality: a systematic review of epidemiological studies ↗. NIHR Open Research 5:51.